| ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up F Honecker, J Aparicio, D Berney, J Beyer, C Bokemeyer, R Cathomas, ... Annals of oncology 29 (8), 1658-1686, 2018 | 300 | 2018 |
| Serum levels of microRNA-371a-3p (M371 test) as a new biomarker of testicular germ cell tumors: results of a prospective multicentric study KP Dieckmann, A Radtke, L Geczi, C Matthies, P Anheuser, U Eckardt, ... Journal of Clinical Oncology 37 (16), 1412, 2019 | 286 | 2019 |
| Serum levels of microRNA miR-371a-3p: a sensitive and specific new biomarker for germ cell tumours KP Dieckmann, A Radtke, M Spiekermann, T Balks, C Matthies, P Becker, ... European urology 71 (2), 213-220, 2017 | 206 | 2017 |
| Involvement of ATM in homologous recombination after end resection and RAD51 nucleofilament formation A Bakr, C Oing, S Köcher, K Borgmann, I Dornreiter, C Petersen, ... Nucleic acids research 43 (6), 3154-3166, 2015 | 141 | 2015 |
| Second line chemotherapy for advanced and metastatic urothelial carcinoma: vinflunine and beyond—a comprehensive review of the current literature C Oing, M Rink, K Oechsle, C Seidel, G von Amsberg, C Bokemeyer The Journal of urology 195 (2), 254-263, 2016 | 125 | 2016 |
| Loss of PTEN-assisted G2/M checkpoint impedes homologous recombination repair and enhances radio-curability and PARP inhibitor treatment response in prostate cancer WY Mansour, P Tennstedt, J Volquardsen, C Oing, M Kluth, C Hube-Magg, ... Scientific reports 8 (1), 3947, 2018 | 69 | 2018 |
| Questioning the Value of Fluorodeoxyglucose Positron Emission Tomography for Residual Lesions After Chemotherapy for Metastatic Seminoma: Results of an International Global … R Cathomas, D Klingbiel, B Bernard, A Lorch, X Garcia del Muro, F Morelli, ... Journal of clinical oncology 36 (34), 3381-3387, 2018 | 58 | 2018 |
| The impact of COVID-19 on oncology professionals: results of the ESMO Resilience Task Force survey collaboration S Banerjee, KHJ Lim, K Murali, K Kamposioras, K Punie, C Oing, ... ESMO open 6 (2), 100058, 2021 | 56 | 2021 |
| Anxiety and depression in long-term testicular germ cell tumor survivors S Vehling, A Mehnert, M Hartmann, C Oing, C Bokemeyer, K Oechsle General Hospital Psychiatry 38, 21-25, 2016 | 56 | 2016 |
| Late adverse effects and quality of life in survivors of testicular germ cell tumour M Chovanec, J Lauritsen, M Bandak, C Oing, GG Kier, M Kreiberg, ... Nature Reviews Urology 18 (4), 227-245, 2021 | 50 | 2021 |
| European Association of Urology guidelines on testicular cancer: 2023 update A Patrikidou, W Cazzaniga, D Berney, J Boormans, I de Angst, D Di Nardo, ... European Urology, 2023 | 47 | 2023 |
| Expression of miRNA‐371a‐3p in seminal plasma and ejaculate is associated with sperm concentration A Radtke, KP Dieckmann, F Grobelny, A Salzbrunn, C Oing, W Schulze, ... Andrology 7 (4), 469-474, 2019 | 42 | 2019 |
| Therapeutic approaches for refractory germ cell cancer C Oing, C Seidel, C Bokemeyer Expert Review of Anticancer Therapy 18 (4), 389-397, 2018 | 39 | 2018 |
| Management of germ cell tumours of the testis in adult patients. German clinical practice guideline part I: epidemiology, classification, diagnosis, prognosis, fertility … S Kliesch, S Schmidt, D Wilborn, C Aigner, W Albrecht, J Bedke, ... Urologia internationalis 105 (3-4), 169-180, 2021 | 38 | 2021 |
| 5-Azacitidine exerts prolonged pro-apoptotic effects and overcomes cisplatin-resistance in non-seminomatous germ cell tumor cells C Oing, I Verem, WY Mansour, C Bokemeyer, S Dyshlovoy, F Honecker International journal of molecular sciences 20 (1), 21, 2018 | 38 | 2018 |
| The detection of isochromosome i (12p) in malignant germ cell tumours and tumours with somatic malignant transformation by the use of quantitative real‐time polymerase chain … A Fichtner, A Richter, S Filmar, NT Gaisa, S Schweyer, H Reis, ... Histopathology 78 (4), 593-606, 2021 | 35 | 2021 |
| Investigational targeted therapies for the treatment of testicular germ cell tumors C Oing, C Kollmannsberger, K Oechsle, C Bokemeyer Expert opinion on investigational drugs 25 (9), 1033-1043, 2016 | 34 | 2016 |
| Platinum-refractory germ cell tumors: an update on current treatment options and developments C Oing, WH Alsdorf, G von Amsberg, K Oechsle, C Bokemeyer World journal of urology 35, 1167-1175, 2017 | 32 | 2017 |
| Retinal toxicity after cisplatin-based chemotherapy in patients with germ cell cancer S Dulz, NH Asselborn, KP Dieckmann, C Matthies, W Wagner, ... Journal of cancer research and clinical oncology 143, 1319-1325, 2017 | 32 | 2017 |
| The component of the m6A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumors V Miranda-Gonçalves, J Lobo, C Guimarães-Teixeira, D Barros-Silva, ... Journal of Experimental & Clinical Cancer Research 40 (1), 268, 2021 | 31 | 2021 |
